RESEARCH ON β-HYDROXYBUTYRIC ACID CONCENTRATION USING ENZYMATIC KINETIC METHOD IN DIABETIC PATIENTS AT CHO RAY HOSPITAL
Main Article Content
Abstract
Objective: This study aimed to determine the serum β-hydroxybutyric acid (BHB) concentration using the enzymatic kinetic method and to investigate its correlation with HbA1c and ketone levels in diabetic patients with ketoacidosis. Subjects and Methods: A cross-sectional descriptive study was conducted on 103 diabetic patients (case group) and 32 healthy individuals (control group) at Cho Ray Hospital from 07/2023 to 07/2024. BHB concentration was measured by the enzymatic kinetic method, HbA1c by high-performance liquid chromatography, and ketones by a semi-quantitative method. Results: The mean BHB concentration in the case group was 4.42 ± 3.51 mmol/L, which was significantly higher than the control group (0.04 ± 0.03 mmol/L) (p < 0.001). BHB showed a strong positive correlation with blood glucose (r = 0.71; p < 0.001) and semi-quantitative blood ketones (r = 0.71; p < 0.001). No significant correlation was found between BHB and HbA1c (r = 0.111; p = 0.264). During treatment monitoring, the mean BHB concentration decreased significantly from 4.43 mmol/L (first test) to 1.91 mmol/L (second test) and 1.0 mmol/L (third test). Conclusion: BHB concentration measured by the enzymatic kinetic method correlates strongly with blood glucose, better reflects the severity of metabolic disturbance, and provides better therapeutic monitoring value than the semi-quantitative ketone method.
Article Details
Keywords
β-hydroxybutyrate, diabetes mellitus, ketoacidosis, enzymatic kinetic, ketone.
References
2. Phùng Thị Thu Phương (2015), Nghiên Cứu Nồng Độ β-Hydroxybutyrate Máu Ở Bệnh Nhân Đái Tháo Đường Ở Việt Nam, Luận văn thạc sĩ, Trường Đại học Khoa học Tự nhiên, Đại học Quốc gia Hà Nội, 2015.
3. American Diabetes Association (ADA) (2022), "Standards of medical care in diabetes-2022 abridged for primary care providers", Clin Diabetes, 2022, 40 (1), pp. 10–38.
4. Han L, Peng QY, Yu J, et al (2025), "Early detection of gastroparesis with diabetic ketoacidosis as initial manifestation: A case-control study", World Journal of Gastroenterology, 2025, 31 (15), pp. 101695.
5. Mahler G, Paulson M, Bonora U, et al (2025), "A retrospective study of diabetic ketoacidosis and initial management", Int J Endocrinol Pract, 2025, 1 (2), pp. 1-2.
6. Nogier K, Kalra J, Lu S, et al (2024), "A-051 Validation and Implementation of the Stanbio Beta-Hydroxybutyrate Assay on Roche c502 Analyzer", Clinical Chemistry, 2024, 70 (Supplement_1), pp. hvae106. 051.
7. Sanchiz MT, Moreno VN, Ruano ML, et al (2025), "Clinical and prognostic differences in diabetic ketoacidosis between type 2 and type 1 diabetes", Medicina clinica, 2025, 165 (1), pp. 106973.
8. Yuzbasioglu Y, Yuce C, Comertpay E, et al (2025), "Determination of Urine Netrin-1 and Beta-Hydroxy Butyrate Levels in Diabetic Ketoacidosis Cases: a Preliminary Report", Clinical Laboratory, 2025, 71 (2), pp. 38-45.